معرفی
Akseli Hemminki is a Professor in the Department of Oncology at the University of Helsinki and a key supervisor in the Doctoral Programme in Integrative Life Science, Biomedicine, and Clinical Research. He is affiliated with the HUS Cancer Center and actively contributes to translational cancer research.
Education/Qualifications:
- Doctor (Medicine), University of Helsinki (1994)
- Docent (Cancer Biology), University of Helsinki (2002)
- Master of Science in Medicine (1999), University of Helsinki
- LL.M. (Medicine), University of Helsinki
- Executive MBA, Aalto University Executive Education (2018)
Research Focus: Dr. Hemminki specializes in cancer gene therapy, immunotherapy, and oncolytic virotherapy. His work bridges genetic predispositions, environmental factors, and innovative treatments for cancers like colorectal, prostate, breast, and renal cell carcinomas.
Scientific Awards:
- American Society of Clinical Oncology Career Development Award (2010)
- Outstanding Young Investigator Award, American Society of Gene Therapy (2007)
- Schering Research Foundation Award (2006)
- Sigrid Juselius Young Investigator Award (2005)
- Outstanding Young Person Award, Junior Chamber International Finland (2006)
PhD Supervision: He has mentored students like Victor Arias, Lyna Haybout, Nea Ojala, Elise Jirovec, and Mirte van der Heijden, focusing on tumor immunology and virotherapy.
Media Engagement: Dr. Hemminki has contributed to cancer discussions on YLE Friday, Morning TV, and Gene Therapy broadcasts.
